Literature DB >> 26873792

Association between radiation dose to the heart and myocardial fatty acid metabolic impairment due to chemoradiation-therapy: Prospective study using I-123 BMIPP SPECT/CT.

Kentaro Takanami1, Akira Arai2, Rei Umezawa2, Takashi Takeuchi3, Noriyuki Kadoya2, Yasuyuki Taki4, Keiichi Jingu2, Kei Takase2.   

Abstract

PURPOSE: To investigate long term changes in myocardial fatty acid metabolic impairment caused by chemoradiation-therapy (CRT).
MATERIALS AND METHODS: We investigated 12 esophageal cancer patients who underwent SPECT/CT using I-123-labeled fatty acid analog (BMIPP) at pre-CRT, pre-boost irradiation, 3-month post-CRT, and 1-year post-CRT. The myocardial uptake was measured using the defect score and the total percentage of uptake (%uptake), which were defined as the sum of the visual scores and that of %uptake in each of 17 segments in the left ventricle (LV), respectively. The correlations between radiation dose to the heart (mean dose, V20, V40, and V60 of the LV and the whole heart (WH)) and the change of myocardial BMIPP uptake from pre-CRT (Δmyocardial BMIPP uptake) were assessed.
RESULTS: At pre-boost, Δmyocardial BMIPP uptake was significantly correlated with LV-V40 and WH-V60. At 3-month post-CRT, Δmyocardial BMIPP uptake was significantly correlated with LV-V40, WH-V40, and WH-V60. However, there were no statistically significant correlations at 1-year post-CRT. Neither mean dose nor V20 of the LV/WH was significantly correlated with Δmyocardial BMIPP uptake at any time.
CONCLUSIONS: In the long term after CRT, myocardial metabolism might be affected by factors other than the radiation dose to the heart.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Fatty acid metabolism; I-123 BMIPP; Radiation-induced heart disease; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 26873792     DOI: 10.1016/j.radonc.2016.01.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Radiation-induced myocardial damage indicated by focal defect on 123I-MIBG SPECT.

Authors:  Takashi Norikane; Yuka Yamamoto; Yasukage Takami; Katsuya Mitamura; Hanae Arai-Okuda; Ryosuke Tani; Yoshihiro Nishiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-15       Impact factor: 9.236

2.  Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study.

Authors:  Rei Umezawa; Noriyuki Kadoya; Hideki Ota; Yujiro Nakajima; Masahide Saito; Hidenobu Takagi; Kentaro Takanami; Noriyoshi Takahashi; Yojiro Ishikawa; Takaya Yamamoto; Haruo Matsushita; Ken Takeda; Kei Takase; Keiichi Jingu
Journal:  Adv Radiat Oncol       Date:  2020-08-05

3.  Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique.

Authors:  Noriko Takata; Masaaki Kataoka; Yasushi Hamamoto; Shintaro Tsuruoka; Hiromitsu Kanzaki; Kotaro Uwatsu; Kei Nagasaki; Teruhito Mochizuki
Journal:  J Radiat Res       Date:  2018-05-01       Impact factor: 2.724

4.  Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma.

Authors:  Markus B Heckmann; Belal Totakhel; Daniel Finke; Markus S Anker; Carsten Müller-Tidow; Uwe Haberkorn; Hugo A Katus; Lorenz H Lehmann
Journal:  ESC Heart Fail       Date:  2019-07-06

5.  Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy.

Authors:  Rebecca Bütof; Laura Häberlein; Christina Jentsch; Jörg Kotzerke; Fabian Lohaus; Sebastian Makocki; Chiara Valentini; Jürgen Weitz; Steffen Löck; Esther G C Troost
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.